Arcutis Biotherapeutics (ARQT)'s 30-day implied volatility (IV30) was 46.3% at the close on October 27, 2026, down from 56.8% the day before, against a 52-week range of 28.0% to 75.4%. Its 20-day historical volatility was 58.1%.
Data as of October 27, 2026.